Thomas Dudler
24Patents
6h-index
16Co-inventors
62Inventor score
Filing activity: Oct 15, 2010 → Aug 15, 2023
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US8652477B2 | Methods for treating disseminated intravascular coagulation by inhibiting MASP-2 dependent complement activation | Chemistry; Metallurgy | 36 | Active |
| US8840893B2 | Methods for treating conditions associated with MASP-2 dependent complement activation | Chemistry; Metallurgy | 22 | Active |
| US8951522B2 | Methods for treating conditions associated with MASP-2 dependent complement activation | Chemistry; Metallurgy | 9 | Active |
| US9011860B2 | Compositions for inhibiting MASP-2 dependent complement activation | Chemistry; Metallurgy | 8 | Active |
| US9644035B2 | Methods for treating conditions associated with MASP-2 dependent complement activation | Chemistry; Metallurgy | 8 | Active |
| US9475885B2 | Compositions for inhibiting MASP-2 dependent complement activation | Chemistry; Metallurgy | 7 | Active |
| US10202465B2 | Methods for treating conditions associated with MASP-2 dependent complement activation | Chemistry; Metallurgy | 0 | Active |
| US11013772B2 | Methods for treating and/or preventing graft-versus-host disease and/or diffuse alveolar hemorrhage and/or veno-occlusive disease associated with hematopoietic stem cell transplant | Chemistry; Metallurgy | 0 | Active |
| US12091468B2 | Therapeutic antibodies that bind to the serine protease domain of MASP-2 and uses thereof | Chemistry; Metallurgy | 0 | Active |
| US11883493B2 | Antibodies specifically binding to MASP-3 for the treatment of various diseases and disorders | Chemistry; Metallurgy | 0 | Active |
| US12005117B2 | Methods for inhibiting fibrosis in a subject in need thereof | Chemistry; Metallurgy | 0 | Active |
| US11027015B2 | Antibodies specifically binding to MASP-3 for the treatment of various diseases and disorders | Chemistry; Metallurgy | 0 | Active |
| US10683367B2 | Compositions for inhibiting MASP-2 dependent complement activation | Chemistry; Metallurgy | 0 | Active |
| US10047165B2 | Compositions for inhibiting MASP-2 dependent complement activation | Chemistry; Metallurgy | 0 | Active |
| US11981748B2 | Methods for inhibiting angiogenesis in a subject in need thereof | Chemistry; Metallurgy | 0 | Active |
| US10745274B1 | Nucleic acids encoding antibodies specifically binding to MASP-3 | Chemistry; Metallurgy | 0 | Active |
| US11896621B2 | Methods for treating and/or preventing graft-versus-host disease and/or diffuse alveolar hemorrhage and/or veno-occlusive disease associated with hematopoietic stem cell transplant | Chemistry; Metallurgy | 0 | Active |
| US11981749B2 | Methods for treating conditions associated with MASP-2 dependent complement activation | Chemistry; Metallurgy | 0 | Active |
| US10870708B2 | Methods for inhibiting angiogenesis in a subject in need thereof | Chemistry; Metallurgy | 0 | Active |
| US11613589B2 | Compositions for inhibiting MASP-2 dependent complement activation | Chemistry; Metallurgy | 0 | Active |
| US10639369B2 | Antibodies specifically binding to MASP-3 for the treatment of various diseases and disorders | Chemistry; Metallurgy | 0 | Active |
| US11525011B2 | Methods of inhibiting MASP-2-dependent complement activation in a subject suffering from catastrophic antiphospholipid syndrome | Chemistry; Metallurgy | 0 | Active |
| US10059776B2 | Methods for treating conditions associated with MASP-2 dependent complement activation | Chemistry; Metallurgy | 0 | Active |
| US11884742B2 | Methods for treating conditions associated with MASP-2 dependent complement activation | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.